Safety and tolerability of high-dose formoterol (via Aerolizer®) and salbutamol in patients with chronic obstructive pulmonary disease

  • Bernd Rosenkranz, Regine Rouzier, Matthias Kruse, Clair Dobson, Gareth Ayre, Ann Horowitz, Serge Fitoussi
  • Respiratory Medicine, April 2006, Elsevier
  • DOI: 10.1016/j.rmed.2005.07.017

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Bernd Rosenkranz